Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

Lunit raises $26M to ramp up sales of AI software

Lunit, a medical software company based out of South Korea, has completed a Series C funding round worth $26 million.

Thumbnail

Toronto-based AI specialists raise $40M in Series B funding

Deep Genomics, a Toronto-based AI company focused on the development of therapeutic drugs, has closed a Series B round of funding worth $40 million.

Thumbnail

MIT, Takeda announce new AI collaboration focused on pharmaceuticals

The MIT School of Engineering has announced a new partnership with Takeda Pharmaceuticals Company Limited to use AI technology to ramp up the development of pharmaceutical drugs.  

Thumbnail

AI startup raises $45M in Series B funding

Paige, a New York-based healthcare startup focused on AI technologies, announced the completion of a Series B funding round worth $45 million.

Thumbnail

Zebra Medical Vision set to bring AI to orthopedic care

Zebra Medical Vision has announced a new collaboration with DePuy Ireland Unlimited Company, agreeing to deploy cloud-based AI solutions focused on orthopedic care.

Thumbnail

AI's role in the Fujifilm/Hitachi acquisition

FUJIFILM Corporation announced Wednesday, Dec. 18, that it has entered into an agreement to purchase Hitachi’s diagnostic imaging business for more than $1.6 billion. AI appears to have played an important role in Fujifilm’s decision.

Thumbnail

Intel acquires AI startup for $2B

Intel Corporation has acquired Habana Labs, a Tel-Aviv, Israel-based AI startup founded in 2016, for approximately $2 billion.

Thumbnail

AI-powered polyp detector gains CE certification

PENTAX Medical, a division of the HOYA Group focused on endoscopic solutions, has received CE mark approval for its AI-powered polyp detector.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”